These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1903725)

  • 1. Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone.
    Shoham Z; Patel A; Jacobs HS
    Fertil Steril; 1991 Jun; 55(6):1051-6. PubMed ID: 1903725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial estradiol response predicts outcome of exogenous gonadotropins using a step-down dose regimen for induction of ovulation in polycystic ovary syndrome.
    Schoot DC; Hop WC; de Jong FH; van Dessel TJ; Fauser BC
    Fertil Steril; 1995 Dec; 64(6):1081-7. PubMed ID: 7589656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
    Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
    Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome.
    Polson DW; Mason HD; Saldahna MB; Franks S
    Clin Endocrinol (Oxf); 1987 Feb; 26(2):205-12. PubMed ID: 3117445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential step-up and step-down dose regimen: an alternative method for ovulation induction with follicle-stimulating hormone in polycystic ovarian syndrome.
    Hugues JN; Cédrin-Durnerin I; Avril C; Bulwa S; Hervé F; Uzan M
    Hum Reprod; 1996 Dec; 11(12):2581-4. PubMed ID: 9021354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of ovulation with purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome.
    Garcea N; Campo S; Panetta V; Venneri M; Siccardi P; Dargenio R; De Tomasi F
    Am J Obstet Gynecol; 1985 Mar; 151(5):635-40. PubMed ID: 3919586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of echographic and endocrine monitoring for the assessment of ovulation by follicle stimulating hormone in polycystic ovarian disease.
    Caruso A; Lanzone A; Fulghesu AM; Apa R; Guida C; Mancuso S
    Int J Gynaecol Obstet; 1989 Feb; 28(2):163-9. PubMed ID: 2563704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation.
    Seibel MM; Kamrava MM; McArdle C; Taymor ML
    Int J Fertil; 1984; 29(1):39-43. PubMed ID: 6146583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective.
    Buvat J; Buvat-Herbaut M; Marcolin G; Dehaene JL; Verbecq P; Renouard O
    Fertil Steril; 1989 Oct; 52(4):553-9. PubMed ID: 2509248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose follicle-stimulating hormone treatment for polycystic ovarian disease.
    Grigoriou O; Antoniou G; Antonaki V; Patsouras C; Zioris C; Karakitsos P
    Int J Gynaecol Obstet; 1996 Jan; 52(1):55-9. PubMed ID: 8620990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of polycystic ovarian syndrome and related variants to low-dose follicle stimulating hormone.
    Yong EL; Ng SC; Chan C; Kumar J; Teo LS; Ratnam S
    Int J Gynaecol Obstet; 1997 Jun; 57(3):305-11. PubMed ID: 9215494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome.
    Dale PO; Tanbo T; Haug E; Abyholm T
    Hum Reprod; 1998 Mar; 13(3):567-70. PubMed ID: 9572412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome.
    van der Meer M; Hompes PG; Scheele F; Schoute E; Veersema S; Schoemaker J
    Hum Reprod; 1994 Sep; 9(9):1612-7. PubMed ID: 7836509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome.
    Farhi J; Jacobs HS
    Fertil Steril; 1997 Mar; 67(3):459-62. PubMed ID: 9091330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome.
    Larsen T; Larsen JF; Schiøler V; Bostofte E; Felding C
    Fertil Steril; 1990 Mar; 53(3):426-31. PubMed ID: 2106449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular development and hormone concentrations following recombinant FSH administration for anovulation associated with polycystic ovarian syndrome: prospective, randomized comparison between low-dose step-up and modified step-down regimens.
    Balasch J; Fábregues F; Creus M; Puerto B; Peñarrubia J; Vanrell JA
    Hum Reprod; 2001 Apr; 16(4):652-6. PubMed ID: 11278212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of a gonadotropin-releasing hormone antagonist on gonadotropin ovulation induction cycles in women with polycystic ovary syndrome: a prospective randomized study.
    Stadtmauer LA; Sarhan A; Duran EH; Beydoun H; Bocca S; Pultz B; Oehninger S
    Fertil Steril; 2011 Jan; 95(1):216-20. PubMed ID: 20594551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome.
    Guido M; Belosi C; Selvaggi L; Lattanzi F; Apa R; Fulghesu AM; Lanzone A
    Gynecol Endocrinol; 2003 Jun; 17(3):215-21. PubMed ID: 12857429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients.
    Shoham Z; Balen A; Patel A; Jacobs HS
    Fertil Steril; 1991 Dec; 56(6):1048-53. PubMed ID: 1743320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.